Humanix Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 136.24%
- Profit Growth 3.40%
- Ebitda 23.75%
- Net Worth 64.98%
- Total Assets 33.84%
About Humanix Lifesciences
Humanix Lifesciences Private Limited (HLPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 May 2016 (Eight years and eight months 9 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Agarwal, Sumit Agarwal, Ruchir Gupta, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24303DL2016PTC300216
- Company No.
300216
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Humanix Lifesciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Agarwal  | Director | 01-Mar-2024 | Current |
| Sumit Agarwal | Director | 01-Mar-2024 | Current |
| Ruchir Gupta | Director | 01-Mar-2024 | Current |
| Parag Kansal | Director | 01-Mar-2024 | Current |
Financial Performance of Humanix Lifesciences.
Humanix Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 136.24% increase. The company also saw a slight improvement in profitability, with a 3.4% increase in profit. The company's net worth Soared by an impressive increase of 64.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Humanix Lifesciences?
In 2021, Humanix Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phd Chamber Of Commerce And IndustrySumit Agarwal is a mutual person
Khushhal Fertiliser LimitedManoj Agarwal is a mutual person
- Goldenyellow Paper Llp
Sumit Agarwal is a mutual person
- Omanand Papers Private Limited
Sumit Agarwal is a mutual person
- Heilsa Life Sciences Private Limited
Sumit Agarwal and Ruchir Gupta are mutual person
- Axa Parenterals Limited
Sumit Agarwal and Ruchir Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Humanix Lifesciences?
Unlock and access historical data on people associated with Humanix Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Humanix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Humanix Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
